Full-Time

Surgical Technologist

Posted on 5/9/2026

Mass General Brigham

Mass General Brigham

1-10 employees

Early-stage life science venture investor

Compensation Overview

$30.12 - $57.18/hr

+ Bonus

Cape Cod, Massachusetts, USA

In Person

Category
Medical, Clinical & Veterinary (1)
Requirements
  • Hold an associate degree in Surgical Technology or be a graduate of an equivalent, accredited Surgical Technologist Program and maintain a certified surgical technologist credential
  • Has successfully completed an accredited school of surgical technology but has not, as of the date of hire, obtained the certified technologist certification, provided that such certification shall be obtained within 12 months of the graduation date
  • Has been employed as a surgical technologist in a surgical facility on July 1, 2013
  • Has successfully completed a training program for surgical technology in the Army, Navy, Air Force, Marine Corps, or Coast Guard of the United States or in the United States Public Health Service (Massachusetts Senate Bill 2058, December 2012)
  • BLS/CPR certification required within one week of hire (American Heart Association and American Red Cross accepted)
  • Surgical Technologist Certification required for SEIU Grade 13
  • Note: One year of Operating Room experience is preferred
Responsibilities
  • Adheres to scope of practice as a Surgical Technologist
  • Maintains a safe operating room environment as prescribed by Hospital policy, AORN and AST Standards of Care, and regulatory requirements
  • Adheres to isolation protocols established by Infection Prevention and standard precautions for blood/body fluid policies utilizing OSHA Standards
  • Maintains a working understanding of, and adherence to, aseptic technique
  • Maintains integrity of sterile field
  • Ensures a safe environment for the perioperative patient and staff
  • Applies knowledge of proper patient positioning
  • Applies knowledge of prepping technique
  • Prepares and understands the specific use of all supplies and equipment used for surgical procedures
  • Anticipates the needs of the surgeon and handles the instruments and supplies, and equipment utilized during the procedure
  • Demonstrates proper procedure for decontamination, cleaning, packaging, and sterilization of special equipment and instruments
  • Must be able to function in CSR to cover needs. Ensures proper preparation of instruments and equipment
  • Participates in surgical time out and surgical debriefing
  • Demonstrates proper specimen collection, identification, and transportation techniques
  • Assists in the preparation and labeling of medications on the sterile field in accordance with regulatory requirements
  • Adheres to department procedure for the prevention of retained surgical items through the proper completion of surgical counts. Communicates results of surgical counts to surgeon
  • Assists in room turnover and in-between case cleaning
  • Assists in maintaining adequate stock of supplies in the surgical suites, clean supply room, and sterile supply room
  • Demonstrates perioperative emergency preparedness (Fire, Code Blue, Malignant Hyperthermia)
  • Performs duties as a preceptor for new hires to surgical technologist position
  • Participates in unit staff meetings, in-service programs and educational programs relative to career development
  • Performs other work-related duties and activities as assigned by supervisor
  • Adheres to the organization’s Code of Conduct and conducts self in a professional manner
  • May be required to float to other areas as helping hands
  • Respects patients’ inherent rights to privacy, dignity and safety
Desired Qualifications
  • Professional Development Certification preferred

Mass General Brigham Ventures funds early-stage life science ideas arising from Mass General Brigham’s research network. It provides first access to deal flow and proprietary rights, backing the formation and growth of new companies and technologies. It uses capital and support to help translate bold innovations into drugs and medical technologies that improve patient outcomes worldwide.

Company Size

1-10

Company Stage

N/A

Total Funding

$1.7B

Headquarters

Cambridge, Massachusetts

Founded

2008

Simplify Jobs

Simplify's Take

What believers are saying

  • 20 exits since inception including eight IPOs and twelve acquisitions demonstrate proven value creation.
  • Strategic focus on digital health and AI positions firm for high-growth healthcare innovation trends.
  • Integrated academic-clinical ecosystem provides technical validation and talent pipeline advantages.

What critics are saying

  • Escalating nurse strikes at Mass General Brigham disrupt operations and damage institutional reputation.
  • Portfolio company failures like Instride erode LP confidence and future fundraising capacity.
  • Competing VCs from non-MGB institutions capture superior deal flow, limiting proprietary advantage.

What makes Mass General Brigham unique

  • Proprietary deal flow from Mass General Brigham's research community and Harvard Medical School faculty.
  • Dedicated AI and Digital Innovation Fund targeting venture-stage healthcare companies since 2020.
  • Active company building support through Amplify program beyond capital provision.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Mass General Brigham who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Flexible Work Hours

Remote Work Options

Hybrid Work Options

Paid Vacation

Paid Sick Leave

Paid Holidays

Family Planning Benefits

Fertility Treatment Support

Professional Development Budget

Conference Attendance Budget

Wellness Program

Mental Health Support

Gym Membership

Phone/Internet Stipend

Home Office Stipend

Stock Options

Company Equity

401(k) Company Match

Parental Leave

Adoption Assistance

Childcare Support

Relocation Assistance

Employee Referral Bonus

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Meal Benefits

Commuter Benefits

Legal Services

Employee Discounts

Company Social Events

Company News

PR Newswire
Mar 19th, 2026
MGB Home Care clinicians to picket Mass General over stalled contract talks after year of bargaining

Approximately 450 clinicians at Mass General Brigham Home Care, represented by the Massachusetts Nurses Association, will hold an informational picket on 24 March outside Massachusetts General Hospital. The clinicians are seeking their first union contract after more than 20 bargaining sessions since March 2025. The bargaining unit includes registered nurses, occupational therapists, physical therapists, speech language pathologists, social workers and dieticians who voted to join the MNA in June 2024. They are demanding reasonable caseload limits, clear productivity standards, competitive wages and recruitment protections. MGB reported a $59.2 million operating gain in the year ending September 2025, with CEO Dr Anne Klibanski's compensation rising 40% to $8.4 million in 2024. The picket is scheduled for 15:30 to 17:00 and is not a strike.

CityBiz
Oct 7th, 2025
Affinia Therapeutics Secures $40M Series C

Avidity Partners has participated in a $40 million Series C funding round for Affinia Therapeutics, a company specializing in adeno-associated virus (AAV) gene therapies.

Business Wire
Oct 4th, 2025
Predicta Biosciences Secures $23.4M to Scale its Novel Diagnostic and Analytics Platform for Blood Cancers and Autoimmune Diseases

Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic discovery solutions, today announced it has raised an oversubs...

PR Newswire
May 7th, 2025
Carta Healthcare Secures $18.25M Series B1 Funding

Carta Healthcare has secured $18 million in Series B1 funding to enhance its AI-powered clinical data abstraction and analytics. The investment, led by UPMC Enterprises with participation from several health ventures, will support Carta's growth in the life sciences market. The funding follows Carta's acquisition of Realyze Intelligence and aims to expand its customer base and improve healthcare data management. CEO Brent Dover highlighted the investment's role in scaling operations and product deployment.

Fierce Biotech
Feb 12th, 2025
Sanofi-backed Abcuro raises $200M series C to fund pivotal trial of KLRG1 antibody

Sanofi-backed Abcuro has secured